Valuation: Medpace Holdings, Inc.

Market Cap 16.98B 14.56B 13.6B 12.48B 23.46B 1,623B 23.85B 160B 62.83B 814B 63.75B 62.36B 2,691B P/E 2026 *
34.6x
P/E 2027 * 31.7x
Enterprise Value 16.18B 13.88B 12.96B 11.89B 22.35B 1,546B 22.72B 153B 59.87B 775B 60.74B 59.41B 2,564B EV / Sales 2026 *
5.67x
EV / Sales 2027 * 5.2x
Free-Float
80.09%
Yield 2026 *
-
Yield 2027 * -
1 day+3.04%
1 week+1.89%
Current month+5.40%
1 month+13.12%
3 months+44.86%
6 months+36.25%
Current year+8.30%
1 week 571.01
Extreme 571.01
612.11
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer - 01/10/2021
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
13/08/26 Sell

Chief Executive Officer

-458 0.0016%
11/08/26 Sell

Director

-1,140 0.0041%
11/08/26 Sell

Chief Executive Officer

-17,610 0.0631%
Change 5-day change 1-year change 3-year change Capi.($)
+3.04%+1.89%+31.62%+143.62% 16.98B
+0.67%+1.96%+2.06%+24.28% 50.5B
-0.62%+4.58%+487.47%+624.71% 46.01B
+2.09%+4.96%+20.59%+95.21% 42.85B
+3.85%+3.13%+29.60%+16.50% 41.03B
-0.72%-3.91%+17.87%+47.98% 32.02B
+4.33%+1.63% - - 17.05B
+1.36%+2.17%+4.07%+33.22% 14.3B
+3.87%+1.98%+82.99%+45.80% 13.84B
+3.26%+3.18%-3.98%-31.10% 13.31B
Average +2.11%+2.13%+74.70%+111.14% 28.79B
Weighted average by Cap. +1.64%+2.41%+99.29%+145.46%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.28B 2.1B 3.94B 273B 4.01B 26.95B 10.55B 137B 10.71B 10.47B 452B 3.03B 2.6B 2.42B 2.22B 4.18B 289B 4.25B 28.61B 11.2B 145B 11.37B 11.12B 480B
Net income 503M 431M 403M 369M 695M 48.03B 706M 4.75B 1.86B 24.09B 1.89B 1.85B 79.65B 547M 469M 438M 402M 755M 52.24B 768M 5.17B 2.02B 26.2B 2.05B 2.01B 86.63B
Net Debt -802M -688M -643M -590M -1.11B -76.68B -1.13B -7.58B -2.97B -38.46B -3.01B -2.95B -127B -1.25B -1.07B -1B -920M -1.73B -120B -1.76B -11.83B -4.63B -60.03B -4.7B -4.6B -198B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
19/08/26 $608.27 +3.04% 169,054
18/08/26 $590.30 -1.14% 131,427
17/08/26 $597.12 +3.22% 163,938
14/08/26 $578.50 -0.59% 220,619
13/08/26 $581.95 -2.52% 151,061
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
608.27USD
Average target price
581.83USD
Spread / Average Target
-4.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock